Glucan-immunostimulant, adjuvant, potential drug

doi:10.5306/wjco.v2.i2.115

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5855)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

489

HTML

5029

Figures (1-1)

337

Sum=5855

Feb 10, 2011 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (80)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Feb 10, 2011; 2(2): 115-119
Published online Feb 10, 2011. doi: 10.5306/wjco.v2.i2.115

Open in New Tab Full Size Figure Download Figure

Figure 1 Stimulation of phagocytosis of synthetic microspheres by the combination of yeast-derived glucan with different types of resveratrol injected ip. Twenty-four hours before the test. Peripheral blood neutrophils with three and more Hydroxy ethyl methacrylate particles were considered positive. PBS: Phosphate buffered saline.

Citation: Vetvicka V. Glucan-immunostimulant, adjuvant, potential drug. World J Clin Oncol 2011; 2(2): 115-119
URL: https://www.wjgnet.com/2218-4333/full/v2/i2/115.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i2.115